Clinical Trial Update: A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of sorafenib in chemonaive metastatic uveal melanoma. The current status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Prof. Dr. med. Max. E. Scheulen | Conditions: Uveal Melanoma | Phase 2 | Status: UNKNOWN